Genmab A (GMAB) Intangibles (2018 - 2026)

Genmab A (GMAB) has reported Intangibles for 9 consecutive years, with $8.9 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Intangibles rose 406.39% year-over-year to $8.9 billion; the trailing twelve-month figure through Jun 2026 stood at $8.9 billion (up 406.39% YoY), and the FY2025 full-year result was $9.1 billion, up 427.95% from the prior year.
• Intangibles fell to $8.9 billion in Q2 2026 per GMAB's latest filing, from $8.9 billion in the prior quarter.
• Across five years, Intangibles topped out at $9.1 billion in Q4 2025 and bottomed at $2.2 million in Q1 2024.
• Historically, Intangibles has averaged $1.8 billion across 5 years, with a median of $25.1 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Intangibles sank 84.49% in 2023, then jumped 125607.93% in 2025.
• Over 5 years, Intangibles stood at $33.3 million in 2022, then tumbled by 84.49% to $5.2 million in 2023, then soared by 40.46% to $7.3 million in 2024, then surged by 125607.93% to $9.1 billion in 2025, then declined by 2.75% to $8.9 billion in 2026.
• According to Business Quant data, Intangibles over the past three periods registered $8.9 billion, $8.9 billion, and $9.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.